Instituto Rosenbusch S.A. (BCBA:ROSE)

Argentina · Delayed Price · Currency is ARS

154.00

0.00 (0.00%)

Last updated: Jul 24, 2026, 3:17 PM BRT

Instituto Rosenbusch Financials Overview

Financials in millions ARS. Fiscal year is January - December.

Millions ARS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,404	6,404	10,886	9,860	4,276	1,523
Revenue Growth	-41.17%	-41.17%	10.40%	130.61%	180.84%	80.56%
Gross Profit	-286.03	-286.03	4,980	2,825	1,974	429.2
Operating Income	-3,369	-3,369	2,461	34.37	875.27	41.98
Net Income	-4,598	-4,598	-1,864	1,226	-25.22	-38.12
Earnings Per Share	-107.95	-107.95	-43.78	28.78	-0.59	-0.90
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Biological Products	2,308	2,308	5,973	5,961	2,030	821.71
Pharmaceutical products	3,134	3,134	4,613	3,725	2,010	638.44
Other Items	165.11	165.11	299.73	174.06	235.76	62.37
Total	5,606	5,606	10,886	9,860	4,276	1,523

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	712.26	712.26	1,154	850.98	331.95	110.95
Total Debt	1,450	1,450	2,289	2,251	1,074	372.01
Net Cash (Debt)	-737.74	-737.74	-1,135	-1,400	-742.22	-261.06
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-17.32	-17.32	-26.66	-32.88	-17.43	-6.13

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	409.89	409.89	720.31	331.37	153.37	58.37
Capital Expenditures	-12.13	-12.13	-13.65	-115.45	-82.63	-4.18
Free Cash Flow	397.75	397.75	706.67	215.92	70.74	54.2
Free Cash Flow Growth	-43.71%	-43.71%	227.27%	205.25%	30.52%	-13.68%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-4.47%	-4.47%	45.75%	28.65%	46.16%	28.19%
Operating Margin	-52.61%	-52.61%	22.61%	0.35%	20.47%	2.76%
Pretax Margin	-69.70%	-69.70%	-17.15%	13.91%	0.76%	-2.50%
Profit Margin	-71.80%	-71.80%	-17.13%	12.43%	-0.59%	-2.50%
FCF Margin	6.21%	6.21%	6.49%	2.19%	1.65%	3.56%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	2.22	-	-
P/FCF Ratio	16.49	25.75	7.35	12.62	7.77	8.64
PS Ratio	1.02	1.60	0.48	0.28	0.13	0.31